全球肿瘤信息系统市场行业概况及 2031 年预测 – 市场分析和市场规模

全球肿瘤信息系统市场 - 行业概况

全球肿瘤信息系统市场正在迅速扩张，推动因素包括癌症发病率上升、技术进步以及对提高肿瘤治疗临床和运营效率的综合解决方案的需求不断增长。根据美国国家癌症研究所 (NCI) 的数据，癌症仍然是全球死亡的主要原因，2022 年报告的新病例近 2000 万例，癌症相关死亡病例 970 万例。OIS 包含一系列软件工具，旨在管理癌症治疗的各个方面，包括电子健康记录 (EHR)、放射治疗计划和化疗管理。市场的增长受到癌症发病率上升和对需要高级数据管理和分析的个性化治疗方法的需求的推动。

Data Bridge 市场研究市场报告提供了最新发展、市场份额、基于细分和区域分析的市场趋势、市场参与者的影响、新兴收入领域机会分析、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地理扩展、市场技术创新的详细信息。要获取有关市场的更多信息，请联系 Data Bridge 市场研究的专家分析师团队。我们的团队将帮助您做出明智的市场决策，以实现业务增长。

全球肿瘤信息系统市场规模

Technological advancements, including cloud-based solutions and artificial intelligence, are significantly advancing the market by providing more accurate diagnostics and optimizing workflows. Furthermore, the use of machine learning algorithms enhances the prediction of patient outcomes and the customization of treatment plans, ultimately improving the overall quality of oncology care. As a result Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Oncology Information Systems Market is increasing at a CAGR of 7.90%. Our detailed analysis forecasts that the market is valued at USD 4.30 billion in 2023 and is expected to grow upto USD 7.91 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.

Global Oncology Information Systems Market Dynamics

Global Oncology Information Systems Market Growth Drivers

Increasing Prevalence of Cancer

According to National Cancer Institute by 2040, the number of new cancer cases per year is expected to rise to 29.9 million and the number of cancer-related deaths to 15.3 million.  As healthcare systems seek to manage the burgeoning volume of cancer patients and improve treatment outcomes, OIS technologies will play a crucial role in enhancing diagnostic precision, streamlining clinical workflows, and supporting personalized care approaches, thereby driving the global oncology information systems market.

Antibiotic Resistance

According to Personalized Medicine Coalition in 2020, personalized medicines accounted for 39 percent of newly approved Neuromuscular Electrical Stimulation (NMEs). The shift towards personalized medicine requires sophisticated data management and analysis tools. OIS systems are essential for tailoring treatment plans to individual patient profiles, thereby driving Global Oncology Information Systems Market growth.

Global Oncology Information Systems Market growth Opportunities

Demand for Streamlining Patient Information

The integration of oncology information systems (OIS) with existing electronic health record (EHR) systems presents Enhanced interoperability between OIS and EHRs which can streamline data management, leading to more efficient workflows and improved patient care. This integration facilitates seamless data exchange and better coordination across healthcare platforms thus fueling Global Oncology Information Systems Market growth.

Government and healthcare initiatives

Government investment in healthcare provides a huge potential opportunity for the global oncology information systems (OIS) market. For instance, the United States government has earmarked around $11.6 billion in 2023 for healthcare IT infrastructure under the "21st Century Cures Act," which intends to improve data interoperability and promote healthcare technologies. Such investments encourage the use and development of OIS solutions. Consequently fostering the Global Oncology Information Systems Market growth.

Global Oncology Information Systems Market growth Challenges

Complexity of System Integration

The System Integration process often requires extensive customization to align OIS with various data sources, electronic health records (EHRs), and other healthcare systems. This integration can disrupt clinical workflows and create operational challenges, as healthcare providers may face difficulties in synchronizing data, managing system compatibility, and ensuring smooth transitions from legacy systems to new technologies. Thus hindering the overall Global Oncology Information Systems Market growth.

Data Security and Privacy Concerns

Protecting sensitive patient information from unauthorized access and breaches is critical due to the increasing number of electronic health records and treatment data. Compliance with various rules, such as Australia's Privacy Act 1988, places rigorous restrictions on how personal data is handled and secured, whereas Canada's Personal Information Protection and Electronic Documents Act (PIPEDA) requires safeguards for personal health information. The high expenses of adopting and maintaining these security measures can be a significant barrier to OIS adoption. As a result, hampering the Global Oncology Information Systems Market growth.

Global Oncology Information Systems Market Restraints

Regulatory and market approval hurdles

The complexity of meeting various regulatory standards causes delays in the approval and deployment of OIS solutions, limiting market entrance and acceptance. For instance, in the European Union, OIS vendors must follow the Medical Device Regulation (MDR), that imposes severe standards for clinical studies and post-market supervision. The regulation necessitates comprehensive paperwork and rigorous testing, which extend the approval process and raise expenses.

Global Oncology Information Systems Market Scope and Trends

• The U.S. Department of Health and Human Services (HHS), via the Office of the National Coordinator for Health Information Technology (ONC), has released the Health Data, Technology, and Interoperability (HTI-2) proposed rule. This initiative underscores ONC’s commitment to enhancing interoperability and improving information exchange among patients, healthcare providers, insurers, and public health agencies.
• New TPS platforms use artificial intelligence and machine learning algorithms to enhance treatment planning and improve dosage administration accuracy. For instance, Varian's ARIA® oncology information system includes AI-powered tools such as SmartSegmentation, which uses machine learning to automate the segmentation of tumors and surrounding tissues, improving radiation therapy planning precision and reducing the time required for manual contouring.
• Surgical oncologists from Chennai's Apollo Cancer Centre (ACC) performed India's first Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for peritoneal surface cancer. The minimally invasive, robotic-assisted method represents a paradigm shift in the treatment of Pseudomyxoma Peritonei (PMP), an aggressive appendix cancer, providing patients with a new standard of care which enables for faster recovery and better quality of life.
• Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS) are becoming more advanced, allowing for highly targeted radiation delivery to tumors while minimizing damage to surrounding healthy tissues.
• C-Care and Healthcare Global Enterprises (HCG) partnered to provide cancer care services in Mauritius. HCG will offer clinical and outpatient consultation (OPD) services at the C-Care Cancer Center, which is housed within C-Care Darné in Floréal.

Global Oncology Information Systems Market Regional Analysis – Market Trends

Key Insights

• The North American market dominates the global Oncology Information Systems (OIS) market driven by high adoption of cutting-edge technologies, and the presence of major industry players. The U.S. leads the region, benefiting from substantial investments in cancer research and the increasing integration of AI in healthcare.
• 亚太地区的 OIS 市场正在快速增长，这得益于医疗支出的增加、癌症发病率的上升以及政府对数字医疗的支持。中国和印度等国家正在对 OIS 基础设施进行大量投资。
• 欧洲 OIS 市场正在稳步增长，推动因素包括医疗支出增加、政府对电子健康记录 (EHR) 的监管以及对 OIS 在改善癌症治疗方面的益处的认识不断提高。

全球肿瘤信息系统市场领先企业

• Koninklijke Philips NV（荷兰）
• 瓦里安医疗系统公司（英国）
• 麦克森公司（美国）
• 西门子（德国）
• Elekta（瑞典）
• Epic Systems Corporation（美国）
• IBM（美国）
• Cerner Corporation（美国）
• 先进数据系统（美国）
• BMSI Partners, Inc.（美国）
• F. Hoffmann-La Roche AG（瑞士）
• AmerisourceBergen Corporation（美国）
• 通用电气（美国）
• Accuray Incorporated（美国）
• OPTUM Inc.，（美国）
• Allscripts Healthcare Solutions, Inc.（美国）
• MICA 信息系统公司（美国）
• CureMD Healthcare（美国）
• EndoSoft LLC（美国）
• RaySearch 实验室（瑞典）

全球肿瘤信息系统市场最新发展

• 2024 年 5 月，RaySearch Laboratories AB 宣布其肿瘤信息系统 RayCare* 2024A 已通过与 Varian TrueBeam 直线加速器版本 3.0 兼容的认证。RaySearch 和 Varian Medical Systems 在 2024 年全年合作进行测试活动，最终获得此项认证。
• 2024 年 4 月，斯德哥尔摩 - Elekta 与 GE HealthCare 收购的领先医学成像管理和人工智能解决方案提供商 MIM Software Inc 宣布合作，将一流的解决方案结合起来，用于放射治疗中的先进治疗计划。
• 2024 年 5 月斯德哥尔摩 - Elekta 宣布推出其最新的直线加速器 (linac) Evo*，这是一款具有全新高清 AI 增强成像的 CT-Linac，可提供离线和在线自适应放射治疗以及更好的传统图像引导放射治疗。这款高度适应性的 CT-Linac 将允许临床医生为每位患者选择最合适的放射治疗技术。

SKU-56104